Vivos Therapeutics, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2023
Total Assets: $10.7M
Liabilities Breakdown FY2023
Total Liabilities: $10.3M
Asset Breakdown
Total Assets: $10.7M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $1.6M | 15.3% |
| Accounts Receivable | $202.0K | 1.9% |
| Inventory | $0 | 0.0% |
| Property, Plant & Equipment | $3.3M | 30.9% |
| Goodwill | $2.8M | 26.5% |
| Intangible Assets | $420.0K | 3.9% |
| Other Assets | $2.3M | 21.5% |
Liabilities Breakdown
Total Liabilities: $10.3M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $2.1M | 20.8% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $8.2M | 79.2% |